Suppr超能文献

[使用CoaguChek进行口服抗凝治疗的患者自我监测]

[Patient self-monitoring of oral anticoagulation with CoaguChek].

作者信息

Caliezi C, Waber M, Pfiffner D, Saner H, Lämmle B, Wuillemin W A

机构信息

Hämatologisches Zentrallabor, Inselspital, Universitätsspital Bern.

出版信息

Schweiz Med Wochenschr. 2000 Jun 17;130(24):916-23.

Abstract

We investigated the feasibility, quality and safety of patient self-control of oral anticoagulation. The patients were selected by their physicians on the basis of criteria such as compliance, skills and motivation. After theoretical and practical training they self-monitored and self-adjusted their anticoagulant dosage for 6 months by weekly self-measurement of their INR values using a capillary whole blood prothrombin time monitor (CoaguChek). Venous INR measurements once a month served as quality control. There were 51 study participants, who performed a median 5 INR measurements per month. 75.8% of all registered INR values were within the recommended individual INR target ranges. The coefficient of correlation between capillary (y) and venous (x) INR values was r = 0.87 (regression analysis y = 1.0 x -0.2). The concordance of capillary and venous INR values was 80% with respect to the individual INR target ranges. There were 5 minor bleeding episodes and no overt thromboembolic recurrences during the study period. In conclusion, the study demonstrated that patient self-control of oral anticoagulation is feasible and achieves a high percentage of INR values within the recommended target ranges. Therefore, self-control of oral anticoagulation can be offered to skilled and motivated patients as an alternative to physician-guided antiocogulation. However, specific training of these selected patients is necessary.

摘要

我们调查了患者自我控制口服抗凝治疗的可行性、质量和安全性。医生根据依从性、技能和积极性等标准挑选患者。经过理论和实践培训后,他们使用毛细管全血凝血酶原时间监测仪(CoaguChek)每周自行测量国际标准化比值(INR)值,自我监测并自行调整抗凝药物剂量,为期6个月。每月进行一次静脉INR测量作为质量控制。共有51名研究参与者,他们每月进行INR测量的中位数为5次。所有记录的INR值中有75.8%在推荐的个体INR目标范围内。毛细管(y)和静脉(x)INR值之间的相关系数r = 0.87(回归分析y = 1.0x - 0.2)。就个体INR目标范围而言,毛细管和静脉INR值的一致性为80%。在研究期间发生了5次轻微出血事件,没有明显的血栓栓塞复发。总之,该研究表明患者自我控制口服抗凝治疗是可行的,并且在推荐的目标范围内能达到较高比例的INR值。因此,对于有技能和积极性的患者,可以提供口服抗凝治疗的自我控制作为医生指导抗凝治疗的替代方案。然而,对这些选定的患者进行特定培训是必要 的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验